198 related articles for article (PubMed ID: 17045356)
1. Release of ibuprofen from beads for embolization: in vitro and in vivo studies.
Borovac T; Pelage JP; Kasselouri A; Prognon P; Guiffant G; Laurent A
J Control Release; 2006 Oct; 115(3):266-74. PubMed ID: 17045356
[TBL] [Abstract][Full Text] [Related]
2. Infrared microspectroscopy analysis of ibuprofen release from drug eluting beads in uterine tissue.
Namur J; Wassef M; Pelage JP; Lewis A; Manfait M; Laurent A
J Control Release; 2009 May; 135(3):198-202. PubMed ID: 19367683
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of ibuprofen-loaded embolization beads in sheep uterus.
Wassef M; Pelage JP; Velzenberger E; Namur J; Schwartz-Cornil I; Taylor RR; Lewis AL; Laurent A
J Biomed Mater Res B Appl Biomater; 2008 Jul; 86(1):63-73. PubMed ID: 18098185
[TBL] [Abstract][Full Text] [Related]
4. IL6 and TNF expression in vessels and surrounding tissues after embolization with ibuprofen-loaded beads confirms diffusion of ibuprofen.
Verret V; Bevilacqua C; Schwartz-Cornil I; Pelage JP; Wassef M; Namur J; Bédouet L; Lewis AL; Martin P; Laurent A
Eur J Pharm Sci; 2011 Apr; 42(5):489-95. PubMed ID: 21329755
[TBL] [Abstract][Full Text] [Related]
5. Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery.
Wang C; He C; Tong Z; Liu X; Ren B; Zeng F
Int J Pharm; 2006 Feb; 308(1-2):160-7. PubMed ID: 16359836
[TBL] [Abstract][Full Text] [Related]
6. Transdermal self-permeation enhancement of ibuprofen.
Al-Saidan SM
J Control Release; 2004 Nov; 100(2):199-209. PubMed ID: 15544868
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
Lamprecht A; Saumet JL; Roux J; Benoit JP
Int J Pharm; 2004 Jul; 278(2):407-14. PubMed ID: 15196644
[TBL] [Abstract][Full Text] [Related]
8. The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans.
Gee CM; Watkinson AC; Nicolazzo JA; Finnin BC
J Pharm Sci; 2014 Mar; 103(3):909-19. PubMed ID: 24421242
[TBL] [Abstract][Full Text] [Related]
9. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
[TBL] [Abstract][Full Text] [Related]
10. Immediate release of ibuprofen from Fujicalin®-based fast-dissolving self-emulsifying tablets.
Kang MJ; Jung SY; Song WH; Park JS; Choi SU; Oh KT; Choi HK; Choi YW; Lee J; Lee BJ; Chi SC
Drug Dev Ind Pharm; 2011 Nov; 37(11):1298-305. PubMed ID: 21476949
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188.
Newa M; Bhandari KH; Li DX; Kwon TH; Kim JA; Yoo BK; Woo JS; Lyoo WS; Yong CS; Choi HG
Int J Pharm; 2007 Oct; 343(1-2):228-37. PubMed ID: 17597315
[TBL] [Abstract][Full Text] [Related]
12. Novel wound models for characterizing ibuprofen release from foam dressings.
Steffansen B; Herping SP
Int J Pharm; 2008 Nov; 364(1):150-5. PubMed ID: 18722518
[TBL] [Abstract][Full Text] [Related]
13. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
[TBL] [Abstract][Full Text] [Related]
14. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
[TBL] [Abstract][Full Text] [Related]
15. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
[TBL] [Abstract][Full Text] [Related]
16. Long-term drug release from electrospun fibers for in vivo inflammation prevention in the prevention of peritendinous adhesions.
Hu C; Liu S; Zhang Y; Li B; Yang H; Fan C; Cui W
Acta Biomater; 2013 Jul; 9(7):7381-8. PubMed ID: 23567943
[TBL] [Abstract][Full Text] [Related]
17. Double barrier as an effective method for slower delivery rate of ibuprofen.
Kurczewska J; Lewandowski D; Olejnik A; Schroeder G; Nowak I
Int J Pharm; 2014 Sep; 472(1-2):248-50. PubMed ID: 24968140
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Non-aqueous Ibuprofen-Phospholipid Complex Formulation in Rats.
Li C; Xu S; Liu Z; Ding L; Zhao X; Lee RJ
In Vivo; 2016; 30(4):479-83. PubMed ID: 27381612
[TBL] [Abstract][Full Text] [Related]
19. Effect of ibuprofen L-lysinate on bilirubin binding to albumin as measured by saturation index and horseradish peroxidase assays.
Ambat MT; Ostrea EM; Aranda JV
J Perinatol; 2008 Apr; 28(4):287-90. PubMed ID: 18200021
[TBL] [Abstract][Full Text] [Related]
20. Bifunctional compounds eliciting both anti-inflammatory and cholinergic activity as potential drugs for neuroinflammatory impairments.
Nizri E; Adani R; Meshulam H; Amitai G; Brenner T
Neurosci Lett; 2005 Mar; 376(1):46-50. PubMed ID: 15694272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
